EGFR and neoplasm: Considering the high specificity and moderate sensitivity of the Idylla EGFR system, some groups recognize this assay as a suitable rapid first screen assay and suggest NGS as a mandatory complementary analysis for samples with no EGFR mutation detected using Idylla or for samples with low amounts of tumour material/DNA39–42.